SID 2026Abstract 0860
Combined talimogene laherparepvec and binimetinib in patients with NRAS-mutated melanoma induces anti-tumor immunity
Yao T, Lui RE, Yamada M, Moore R, Jimenez M, Cornelius L, Ansstas G, Saligrama N, Chen D
SID Annual Meeting 2026Pigmentation & melanomaChicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: Skin cancer & tumorsMelanoma & molesCancer drugs
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.891 · Not in PubMed: details from Crossref